Does early enteral nutrition reduce surgical site infection in children with asthma? A quality-improvement audit
Published
June 17, 2026
Paper ID
PAP-000159
Status
Published
DOI
10.65712/tmj.test000417
Advance Services
Abstract
Background: surgical site infection remains a leading cause of avoidable harm among children with asthma. Methods: We conducted a quality-improvement audit across 9 centres between 2016 and 2022. Results: Effects were consistent across prespecified subgroups. Effects were consistent across prespecified subgroups. Conclusion: Implementation will depend on staffing, cost and local protocols.
Introduction
Guidelines make only a weak recommendation on early enteral nutrition.
Practice around early enteral nutrition varies widely between centres. Earlier studies of early enteral nutrition were small or single-centre.
Guidelines make only a weak recommendation on early enteral nutrition. Practice around early enteral nutrition varies widely between centres.
Practice around early enteral nutrition varies widely between centres. Guidelines make only a weak recommendation on early enteral nutrition. The cost of surgical site infection to health systems is substantial.
Discussion
Residual confounding cannot be excluded. Future work should test early enteral nutrition in a pragmatic multicentre trial.
Future work should test early enteral nutrition in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.
Residual confounding cannot be excluded. Future work should test early enteral nutrition in a pragmatic multicentre trial.
Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment. Future work should test early enteral nutrition in a pragmatic multicentre trial.
Strengths include the sample size and blinded outcome assessment. These findings suggest that early enteral nutrition is associated with better surgical site infection in children with asthma.
Conclusions
Early enteral nutrition may be offered for children with asthma to improve surgical site infection.
References
1. Kim Q, Kaur N, et al. Tranexamic acid and chronic pain scores. Pediatrics. 2024;177(6):462-1177.
2. Ahmed I, Silva H, et al. High-flow nasal oxygen and emergency department revisits. Diabetes Care. 2012;24(4):833-998.
3. Andersen B, Tanaka S, et al. Prone positioning and medication adherence. JAMA. 2022;362(4):838-1673.
4. Costa O, Rossi G, et al. Low-dose aspirin and health-related quality of life. BMJ. 2024;308(2):497-1245.
5. Zhang K, Mensah A, et al. Pharmacist-led medication review and patient satisfaction. Lancet. 2022;400(7):681-1730.
6. Lindqvist S, Okafor K, et al. Delayed cord clamping and acute kidney injury. BMC Med. 2013;291(1):897-1065.
7. Yilmaz E, Schmidt M, et al. Tranexamic acid and chronic pain scores. Eur Heart J. 2010;181(6):569-940.
8. Dubois P, Dubois W, et al. Prone positioning and glycaemic control. Diabetes Care. 2008;76(6):748-1544.
Appendices
Ethics approval: IRB-8754.
Materials and Methods
Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
The primary outcome was surgical site infection, assessed blind to allocation. Missing data were handled with multiple imputation. Eligible participants were children with asthma.
Results
The adjusted odds ratio was 0.64 (95% CI 0.25 to 0.89). The adjusted odds ratio was 0.80 (95% CI 0.28 to 0.75). Serious adverse events were rare and similar between groups. surgical site infection occurred in 21% of the intervention group versus 31% of controls.
surgical site infection occurred in 17% of the intervention group versus 29% of controls. surgical site infection occurred in 22% of the intervention group versus 20% of controls.
The adjusted odds ratio was 0.76 (95% CI 0.23 to 0.60). surgical site infection occurred in 20% of the intervention group versus 37% of controls.
| Group | n | Events | Rate % |
|---|---|---|---|
| Age < 65 | 484 | 45 | 39.9 |
| Male | 489 | 73 | 23.2 |
| Centre B | 242 | 85 | 33.2 |
| Control | 162 | 110 | 36.5 |
| Centre B | 871 | 45 | 28.5 |
| Age ≥ 65 | 274 | 52 | 25.2 |
| Centre B | 176 | 53 | 22.1 |
Values are n (%) unless stated otherwise.

Shown for children with asthma; error bars are 95% confidence intervals.

Shown for children with asthma; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.44 (95% CI 0.38 to 0.68). Effects were consistent across prespecified subgroups.
1794 participants were included (median age 82 years). 1909 participants were included (median age 50 years). 3079 participants were included (median age 33 years). Effects were consistent across prespecified subgroups.